LRP4 and myasthenia gravis: Approximately 80% of MG patients present with autoantibodies against AChR, while a smaller subset is seropositive for antibodies targeting muscle-specific kinase (MuSK), low-density lipoprotein receptor-related protein 4 (LRP4), or agrin (2).